Cardiovascular DiseasesCardiovascular MorbiditySubclinical Organ DamageDigital Health
Study summary
To comprehensively evaluate subclinical organ damage of Chinese adults and its association with future cardiovascular disease and events.
To observe the significance of intervention based on digital health in preventing the onset and/or progression of subclinical organ damage and cardiovascular disease and events.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* aged 18 years or older
* willing to participate the study and sign informed consent
* available for long-term follow-up
Exclusion Criteria:
* severe heart disease (NYHA IV)
* stage 4 or 5 CKD
* malignant tumors or with life expectancy less than 5 years
* stroke within 3 months
* refuse to participate the study or not available for long-term follow up
Primary outcome measure(s)
composite endpoint of cardiovascular events — 5 years rate of subject with myocardial infarction, stroke, heart failure, cardiovascular death
Trial sites (1)
Facility
City
Region
Status
Shanghai Tenth People's Hospital, Tongji University School of Medicine
Shanghai
Shanghai Municipality
More Shanghai 10th People's Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.